1-5 of 5
Paolo Corradini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma

Chiara Monfrini, Federico Stella, Vanessa Aragona, Martina Magni, Silva Ljevar, Cristina Vella, Eugenio Fardella, Annalisa Chiappella, Francesca Nanetti, Martina Pennisi, Anna Dodero, Anna Guidetti, Paolo Corradini, Cristiana Carniti
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3378–3386.
https://doi.org/10.1158/1078-0432.CCR-22-0164
Published: 02 August 2022
View article titled, Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <em>In Vivo</em> Expansion and Disease Response in Patients with Large B-cell Lymphoma
Open the PDF for Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects <em>In Vivo</em> Expansion and Disease Response in Patients with Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma

Bachisio Ziccheddu, Matteo C. Da Vià, Marta Lionetti, Akihiro Maeda, Silvia Morlupi, Matteo Dugo, Katia Todoerti, Stefania Oliva, Mattia D'Agostino, Paolo Corradini, Ola Landgren, Francesco Iorio, Loredana Pettine, Alessandra Pompa, Martina Manzoni, Luca Baldini, Antonino Neri, Francesco Maura, Niccolò Bolli
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6479–6490.
https://doi.org/10.1158/1078-0432.CCR-20-4366
Published: 01 December 2021
View article titled, Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
Open the PDF for Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients

Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra, Alessandra Romano, Anna Marina Liberati, Donato Mannina, Paolo de Fabritiis, Nicola Cascavilla, Marina Ruggeri, Roberto Mina, Francesca Patriarca, Giulia Benevolo, Angelo Belotti, Gianluca Gaidano, Arnon Nagler, Roman Hájek, Andrew Spencer, Pieter Sonneveld, Pellegrino Musto, Mario Boccadoro, Francesca Gay
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3695–3703.
https://doi.org/10.1158/1078-0432.CCR-21-0134
Published: 01 July 2021
View article titled, Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Open the PDF for Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients in another window
Includes: Supplementary data
Journal Articles

Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Camilla Recordati, Davide Confalonieri, Anisa Bermema, Paolo Corradini, Jacopo Mariotti
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16): 3740–3749.
https://doi.org/10.1158/1078-0432.CCR-14-2758
Published: 13 August 2015
View article titled, Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects
Open the PDF for Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases

Anna Guidetti, Carmelo Carlo-Stella, Silvia L. Locatelli, Walter Malorni, Roberta Mortarini, Simonetta Viviani, Domenico Russo, Alfonso Marchianò, Roberto Sorasio, Anna Dodero, Lucia Farina, Laura Giordano, Massimo Di Nicola, Andrea Anichini, Paolo Corradini, Alessandro M. Gianni
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5641–5651.
https://doi.org/10.1158/1078-0432.CCR-14-0770
Published: 13 November 2014
View article titled, Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases
Open the PDF for Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases in another window
Includes: Supplementary data